R&D Partnering

WHERE SCIENCE IS COLLABORATIVE.

We engage with innovative ecosystems around the world that complement our internal capabilities to translate science into highly transformative or curative potential medicines for targeted populations with high unmet need.

200+
Active collaborations
Takeda has in place globally

~100
Public-Private partnerships
engaged in through R&D across
76 countries

>60%
Of our pipeline is partnered
allowing us to tap cutting-edge
science and innovation at the source

We seek innovation and partner to nurture it, wherever it resides.

Partnership is a central element of our R&D strategy. We work with partners to create complementary collaborations where our global reach, scientific expertise and clinical excellence can help them bring their scientific innovation and vision to patients.

Center for External Innovation

Our R&D Center for External Innovation (CEI) is an integrated team driving innovation from target identification through clinical development and
commercialization. Within CEI, our unique model supports diverse and flexible partnerships around the world to harness innovation across the discovery and development lifecycle.

Public-Private Partnerships

We recognize that many scientific challenges we face are too large and complex for any one organization to tackle by itself. We are stronger when we work precompetitively and collaborate to advance our R&D efforts more efficiently and effectively to deliver transformative medicines to patients.

Our diverse and flexible approach to partnering continuously enables innovation

Our team drives external engagement for opportunities ranging from early academic research to late-stage clinical collaborations with the aim to form innovative partnerships, which elevate our internal research capabilities and strengthen our pipeline.